2015-2016年北卡罗来纳州45-75岁被监禁女性的绝经相关药物使用情况

IF 1.1 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Elana Jaffe, David Rosen, Aunchalee Palmquist, Andrea K Knittel
{"title":"2015-2016年北卡罗来纳州45-75岁被监禁女性的绝经相关药物使用情况","authors":"Elana Jaffe, David Rosen, Aunchalee Palmquist, Andrea K Knittel","doi":"10.1108/IJPH-07-2021-0068","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to estimate the prevalence of individuals receiving hormone therapy for menopause management and the prevalence of underlying conditions that may constrain options for pharmacologic menopause management in the prison context.</p><p><strong>Design/methodology/approach: </strong>This study reviewed all prescriptions dispensed by the North Carolina Department of Public Safety between July 1, 2015, and June 30, 2016, for relevance to menopause management. Relevant medications were those either recommended for menopause management or those indicated for management of conditions that may complicate menopause management, as per the 2015 clinical decision-support algorithm tool developed by the North American Menopause Society. Analysis was restricted to women between the ages of 45 and 75.</p><p><strong>Findings: </strong>Of 1,120 women, a majority (77.8%) were between the ages of 45 and 54. Less than 5% of individuals in this study were prescribed estrogen-containing therapy. The most commonly prescribed medications that may constrain options for menopause treatment were related to hypertension and other cardiovascular disease or mental health conditions.</p><p><strong>Research limitations/implications: </strong>The retrospective nature of this data set limits the findings, given that researchers did not have access to diagnoses or data on polypharmacy. Still, this study indicates that many women over 45 experiencing incarceration are living with health conditions that may complicate menopause symptom management with hormone therapy. Future research in carceral settings must examine the prevalence of menopause-related symptoms as well as access to and quality of comprehensive menopause management.</p><p><strong>Originality/value: </strong>There is a paucity of literature around the menopause-related needs of individuals experiencing incarceration. To the best of the authors' knowledge, no other research has examined prevalence of pharmacologic menopause management among women who are incarcerated.</p>","PeriodicalId":45561,"journal":{"name":"International Journal of Prisoner Health","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2022-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Menopause-related medication use among women age 45-75 experiencing incarceration in North Carolina 2015-2016.\",\"authors\":\"Elana Jaffe, David Rosen, Aunchalee Palmquist, Andrea K Knittel\",\"doi\":\"10.1108/IJPH-07-2021-0068\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study aims to estimate the prevalence of individuals receiving hormone therapy for menopause management and the prevalence of underlying conditions that may constrain options for pharmacologic menopause management in the prison context.</p><p><strong>Design/methodology/approach: </strong>This study reviewed all prescriptions dispensed by the North Carolina Department of Public Safety between July 1, 2015, and June 30, 2016, for relevance to menopause management. Relevant medications were those either recommended for menopause management or those indicated for management of conditions that may complicate menopause management, as per the 2015 clinical decision-support algorithm tool developed by the North American Menopause Society. Analysis was restricted to women between the ages of 45 and 75.</p><p><strong>Findings: </strong>Of 1,120 women, a majority (77.8%) were between the ages of 45 and 54. Less than 5% of individuals in this study were prescribed estrogen-containing therapy. The most commonly prescribed medications that may constrain options for menopause treatment were related to hypertension and other cardiovascular disease or mental health conditions.</p><p><strong>Research limitations/implications: </strong>The retrospective nature of this data set limits the findings, given that researchers did not have access to diagnoses or data on polypharmacy. Still, this study indicates that many women over 45 experiencing incarceration are living with health conditions that may complicate menopause symptom management with hormone therapy. Future research in carceral settings must examine the prevalence of menopause-related symptoms as well as access to and quality of comprehensive menopause management.</p><p><strong>Originality/value: </strong>There is a paucity of literature around the menopause-related needs of individuals experiencing incarceration. To the best of the authors' knowledge, no other research has examined prevalence of pharmacologic menopause management among women who are incarcerated.</p>\",\"PeriodicalId\":45561,\"journal\":{\"name\":\"International Journal of Prisoner Health\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2022-06-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Prisoner Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1108/IJPH-07-2021-0068\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Prisoner Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1108/IJPH-07-2021-0068","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究旨在估计接受激素治疗绝经管理的个体的患病率,以及可能限制药物绝经管理选择的潜在疾病的患病率。设计/方法/方法本研究回顾了2015年7月1日至2016年6月30日期间北卡罗莱纳州公共安全部开具的与更年期管理相关的所有处方。根据北美更年期协会开发的2015年临床决策支持算法工具,相关药物是推荐用于更年期管理的药物,或用于管理可能使更年期管理复杂化的疾病的药物。分析仅限于年龄在45到75岁之间的女性。在1120名女性中,大多数(77.8%)年龄在45岁至54岁之间。在这项研究中,只有不到5%的人接受了含雌激素的治疗。最常见的可能限制更年期治疗选择的处方药与高血压和其他心血管疾病或精神健康状况有关。研究局限性/意义考虑到研究人员无法获得多药的诊断或数据,该数据集的回顾性性质限制了研究结果。尽管如此,这项研究表明,许多45岁以上被监禁的女性的健康状况可能会使激素治疗的更年期症状管理复杂化。未来的研究必须检查绝经相关症状的患病率以及全面绝经管理的可及性和质量。原创性/价值关于经历监禁的个体的更年期相关需求的文献很少。据作者所知,没有其他研究调查过在监禁妇女中药物绝经管理的流行程度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Menopause-related medication use among women age 45-75 experiencing incarceration in North Carolina 2015-2016.

Purpose: This study aims to estimate the prevalence of individuals receiving hormone therapy for menopause management and the prevalence of underlying conditions that may constrain options for pharmacologic menopause management in the prison context.

Design/methodology/approach: This study reviewed all prescriptions dispensed by the North Carolina Department of Public Safety between July 1, 2015, and June 30, 2016, for relevance to menopause management. Relevant medications were those either recommended for menopause management or those indicated for management of conditions that may complicate menopause management, as per the 2015 clinical decision-support algorithm tool developed by the North American Menopause Society. Analysis was restricted to women between the ages of 45 and 75.

Findings: Of 1,120 women, a majority (77.8%) were between the ages of 45 and 54. Less than 5% of individuals in this study were prescribed estrogen-containing therapy. The most commonly prescribed medications that may constrain options for menopause treatment were related to hypertension and other cardiovascular disease or mental health conditions.

Research limitations/implications: The retrospective nature of this data set limits the findings, given that researchers did not have access to diagnoses or data on polypharmacy. Still, this study indicates that many women over 45 experiencing incarceration are living with health conditions that may complicate menopause symptom management with hormone therapy. Future research in carceral settings must examine the prevalence of menopause-related symptoms as well as access to and quality of comprehensive menopause management.

Originality/value: There is a paucity of literature around the menopause-related needs of individuals experiencing incarceration. To the best of the authors' knowledge, no other research has examined prevalence of pharmacologic menopause management among women who are incarcerated.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Prisoner Health
International Journal of Prisoner Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
2.80
自引率
21.40%
发文量
56
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信